Dexamethasone and Flibanserin interaction

Dexamethasone and Flibanserin: the Flibanserin prescribing label flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Flibanserin (ADDYI) label · effective 2025-12-22

Major

Preventing or Managing DI The concomitant use of ADDYI with CYP3A4 inducers is not recommended.

Drug interactionsby drug classView label on DailyMed
Major

CYP3A4 Inducers : Use of ADDYI not recommended; flibanserin concentrations substantially reduced (7)

Drug interactionsby drug classView label on DailyMed
Moderate

John's Wort Clinical Implications The concomitant use of ADDYI with CYP3A4 inducers substantially decreases flibanserin exposure compared to the use of ADDYI alone.

Drug interactionsby drug classView label on DailyMed
Minor

CYP3A4 Inducers Examples Carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapetine, St.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.